About Us
As a pioneering high-tech enterprise,
we take immense pride in our unwavering commitment to innovation, high quality, and customer satisfaction.
Our Story
Found in 2011, LePure Biotech is a cutting-edge high-tech enterprise at the forefront of research and development, specializing in the production of single-use equipment and consumables. Our unwavering dedication lies in delivering top-notch, groundbreaking single-use bioprocess solutions for the biopharmaceutical industry, setting new standards in quality and innovation. With multiple state-of-the-art production plants and vertically integrated process staring from film production, we possess a unique advantage that sets us apart.
Our extensive network allows us to shorten lead times significantly, ensuring your projects are executed with unparalleled speed and efficiency. Not only does this expedite your bio-pharmaceutical manufacturing process, but it also enables you to stay ahead in the dynamic and competitive market.
LePure Biotech boasts several production plants in Songjiang, Shanghai, Tianjin, Suzhou, and the South China Bay Area. Moreover, the company features an innovative R&D center in Boston, USA and maintains a dedicated business office in Korea.
Figures about LePure Biotech
8
Worldwide Locations
5000+m²
Good Manufacturing Practice (GMP) Area
1000+
Employees Worldwide in 2023
700+
Business Partners Worldwide
Timeline
2011
Established in 2011, specializes in the development and localization of single-use bioprocess technology.
2012
Secured angel investment and successfully established a LePure’s first Class C clean manufacturing facility in the vibrant city of Shanghai
2015
LePure Biotech has been honored with the prestigious recognition as a nationally acclaimed high-tech enterprise
2019
Our groundbreaking “Special Nutrient Storage Solution and Products for Outer Space Breeding” embarked on an historic journey alongside China’s Chang’e 4 mission to the Moon.
In the same year, LePure Biotech received the Shanghai Songjiang Science and Technology Innovation Award.
2021
Achieved a significant milestone with the establishment of its state-of-the-art US-based R&D center in Massachusetts. Additionally, the company garnered substantial investments from top-tier investors such as Legend Capital and Hillhouse China, further fortifying its industry presence.
2022
LePure Biotech’s strategic acquisitions of Geshi Filter and QuaCell Biotech have transformed it into a leading biotechnology solutions provider, seamlessly integrating pharmaceutical filtration technology and cell culture development expertise. The company has gained the support of top-tier investors such as NOVO, GA, and GS, while also achieving dual ISO13485 and ISO9001 certifications. LePure Biotech’s outstanding growth was further acknowledged with the Shanghai Hundreds Growing Business award, cementing its position as an industry leader.
2023
Acquisition of Sterist and the subsequent integration of comprehensive clean management solutions have significantly broadened the company’s business portfolio.
Bioprocess Solution
Our production process enables us to optimize costs without compromising on the quality of our single-use equipment and consumables. LePure Biotech remains dedicated to delivering cost-effective solutions without compromising the cutting-edge technology and reliability that we are renowned for.
Empower Biopharma through High Quality Bioprocess Solutions
Join hands with LePure Biotech, where innovation meets efficiency, and experience the power of streamlined bioprocessing solutions that elevate your productivity, reduce expenses, and accelerate your path to success.
